Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 239 entries
Sorted by: Best Match Show Resources per page
Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery.

Molecular therapy. Methods & clinical development

Suwanmanee T, Ferris MT, Hu P, Gui T, Montgomery SA, Pardo-Manuel de Villena F, Kafri T.
PMID: 28480308
Mol Ther Methods Clin Dev. 2017 Apr 05;5:83-92. doi: 10.1016/j.omtm.2017.03.009. eCollection 2017 Jun 16.

The success of lentiviral vectors in curing fatal genetic and acquired diseases has opened a new era in human gene therapy. However, variability in the efficacy and safety of this therapeutic approach has been reported in human patients. Consequently,...

Cite
Suwanmanee T, Ferris MT, Hu P, et al. Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery. Mol Ther Methods Clin Dev. 2017;5:83-92doi: 10.1016/j.omtm.2017.03.009.
Suwanmanee, T., Ferris, M. T., Hu, P., Gui, T., Montgomery, S. A., Pardo-Manuel de Villena, F., & Kafri, T. (2017). Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery. Molecular therapy. Methods & clinical development, 583-92. https://doi.org/10.1016/j.omtm.2017.03.009
Suwanmanee, Thipparat, et al. "Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery." Molecular therapy. Methods & clinical development vol. 5 (2017): 83-92. doi: https://doi.org/10.1016/j.omtm.2017.03.009
Suwanmanee T, Ferris MT, Hu P, Gui T, Montgomery SA, Pardo-Manuel de Villena F, Kafri T. Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery. Mol Ther Methods Clin Dev. 2017 Apr 05;5:83-92. doi: 10.1016/j.omtm.2017.03.009. eCollection 2017 Jun 16. PMID: 28480308; PMCID: PMC5415322.
Copy Download .nbib Format: NLM
Characterization of candidate genes in inflammatory bowel disease-associated risk loci.

JCI insight

Peloquin JM, Goel G, Kong L, Huang H, Haritunians T, Sartor RB, Daly MJ, Newberry RD, McGovern DP, Yajnik V, Lira SA, Xavier RJ.
PMID: 27668286
JCI Insight. 2016 Aug 18;1(13):e87899. doi: 10.1172/jci.insight.87899.

GWAS have linked SNPs to risk of inflammatory bowel disease (IBD), but a systematic characterization of disease-associated genes has been lacking. Prior studies utilized microarrays that did not capture many genes encoded within risk loci or defined expression quantitative...

Cite
Peloquin JM, Goel G, Kong L, et al. Characterization of candidate genes in inflammatory bowel disease-associated risk loci. JCI Insight. 2016;1(13):e87899doi: 10.1172/jci.insight.87899.
Peloquin, J. M., Goel, G., Kong, L., Huang, H., Haritunians, T., Sartor, R. B., Daly, M. J., Newberry, R. D., McGovern, D. P., Yajnik, V., Lira, S. A., & Xavier, R. J. (2016). Characterization of candidate genes in inflammatory bowel disease-associated risk loci. JCI insight, 1(13), e87899. https://doi.org/10.1172/jci.insight.87899
Peloquin, Joanna M, et al. "Characterization of candidate genes in inflammatory bowel disease-associated risk loci." JCI insight vol. 1,13 (2016): e87899. doi: https://doi.org/10.1172/jci.insight.87899
Peloquin JM, Goel G, Kong L, Huang H, Haritunians T, Sartor RB, Daly MJ, Newberry RD, McGovern DP, Yajnik V, Lira SA, Xavier RJ. Characterization of candidate genes in inflammatory bowel disease-associated risk loci. JCI Insight. 2016 Aug 18;1(13):e87899. doi: 10.1172/jci.insight.87899. PMID: 27668286; PMCID: PMC5033062.
Copy Download .nbib Format: NLM
Breast Cancer Knowledge, Behaviors, and Preferences in Malawi: Implications for Early Detection Interventions From a Discrete Choice Experiment.

Journal of global oncology

Kohler RE, Gopal S, Lee CN, Weiner BJ, Reeve BB, Wheeler SB.
PMID: 29094086
J Glob Oncol. 2017 Apr 21;3(5):480-489. doi: 10.1200/JGO.2016.005371. eCollection 2017 Oct.

PURPOSE: Breast cancer is the most common female cancer in Africa and leading cause of death resulting from cancer; however, many countries lack early detection services. In Malawi, women are frequently diagnosed with large tumors after long symptomatic periods....

Cite
Kohler RE, Gopal S, Lee CN, et al. Breast Cancer Knowledge, Behaviors, and Preferences in Malawi: Implications for Early Detection Interventions From a Discrete Choice Experiment. J Glob Oncol. 2017;3(5):480-489doi: 10.1200/JGO.2016.005371.
Kohler, R. E., Gopal, S., Lee, C. N., Weiner, B. J., Reeve, B. B., & Wheeler, S. B. (2017). Breast Cancer Knowledge, Behaviors, and Preferences in Malawi: Implications for Early Detection Interventions From a Discrete Choice Experiment. Journal of global oncology, 3(5), 480-489. https://doi.org/10.1200/JGO.2016.005371
Kohler, Racquel E, et al. "Breast Cancer Knowledge, Behaviors, and Preferences in Malawi: Implications for Early Detection Interventions From a Discrete Choice Experiment." Journal of global oncology vol. 3,5 (2017): 480-489. doi: https://doi.org/10.1200/JGO.2016.005371
Kohler RE, Gopal S, Lee CN, Weiner BJ, Reeve BB, Wheeler SB. Breast Cancer Knowledge, Behaviors, and Preferences in Malawi: Implications for Early Detection Interventions From a Discrete Choice Experiment. J Glob Oncol. 2017 Apr 21;3(5):480-489. doi: 10.1200/JGO.2016.005371. eCollection 2017 Oct. PMID: 29094086; PMCID: PMC5646878.
Copy Download .nbib Format: NLM
SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin.

Molecular biology of the cell

Ohkuni K, Takahashi Y, Fulp A, Lawrimore J, Au WC, Pasupala N, Levy-Myers R, Warren J, Strunnikov A, Baker RE, Kerscher O, Bloom K, Basrai MA.
PMID: 26960795
Mol Biol Cell. 2016 Mar 09; doi: 10.1091/mbc.E15-12-0827. Epub 2016 Mar 09.

Centromeric histone H3, CENP-A

Cite
Ohkuni K, Takahashi Y, Fulp A, et al. SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin. Mol Biol Cell. 2016;doi: 10.1091/mbc.E15-12-0827.
Ohkuni, K., Takahashi, Y., Fulp, A., Lawrimore, J., Au, W. C., Pasupala, N., Levy-Myers, R., Warren, J., Strunnikov, A., Baker, R. E., Kerscher, O., Bloom, K., & Basrai, M. A. (2016). SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin. Molecular biology of the cell, . https://doi.org/10.1091/mbc.E15-12-0827
Ohkuni, Kentaro, et al. "SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin." Molecular biology of the cell vol. (2016). doi: https://doi.org/10.1091/mbc.E15-12-0827
Ohkuni K, Takahashi Y, Fulp A, Lawrimore J, Au WC, Pasupala N, Levy-Myers R, Warren J, Strunnikov A, Baker RE, Kerscher O, Bloom K, Basrai MA. SUMO-Targeted Ubiquitin Ligase (STUbL) Slx5 regulates proteolysis of centromeric histone H3 variant Cse4 and prevents its mislocalization to euchromatin. Mol Biol Cell. 2016 Mar 09; doi: 10.1091/mbc.E15-12-0827. Epub 2016 Mar 09. PMID: 26960795; PMCID: PMC4850037.
Copy Download .nbib Format: NLM
An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity.

JACC. Basic to translational science

Beak J, Huang W, Parker JS, Hicks ST, Patterson C, Simpson PC, Ma A, Jin J, Jensen BC.
PMID: 28286875
JACC Basic Transl Sci. 2017 Feb;2(1):39-53. doi: 10.1016/j.jacbts.2016.10.006.

α1A-ARs play adaptive and protective roles in the heart. Dabuzalgron is an oral selective α1A-AR agonist that was well tolerated in multiple clinical trials of treatment for urinary incontinence, but has never been used to treat heart disease in...

Cite
Beak J, Huang W, Parker JS, et al. An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity. JACC Basic Transl Sci. 2017;2(1):39-53doi: 10.1016/j.jacbts.2016.10.006.
Beak, J., Huang, W., Parker, J. S., Hicks, S. T., Patterson, C., Simpson, P. C., Ma, A., Jin, J., & Jensen, B. C. (2017). An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity. JACC. Basic to translational science, 2(1), 39-53. https://doi.org/10.1016/j.jacbts.2016.10.006
Beak, JuYoun, et al. "An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity." JACC. Basic to translational science vol. 2,1 (2017): 39-53. doi: https://doi.org/10.1016/j.jacbts.2016.10.006
Beak J, Huang W, Parker JS, Hicks ST, Patterson C, Simpson PC, Ma A, Jin J, Jensen BC. An Oral Selective Alpha-1A Adrenergic Receptor Agonist Prevents Doxorubicin Cardiotoxicity. JACC Basic Transl Sci. 2017 Feb;2(1):39-53. doi: 10.1016/j.jacbts.2016.10.006. PMID: 28286875; PMCID: PMC5343290.
Copy Download .nbib Format: NLM
Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss.

Gastrointestinal cancer : targets and therapy

Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, Snavely A, Rogers AB, Montgomery SA, Rathmell WK, McRee AJ.
PMID: 25844041
Gastrointest Cancer. 2015 Feb 01;5:61-71. doi: 10.2147/GICTT.S72274.

No abstract available.

Cite
Sendor AB, Hacker KE, Chen S, et al. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointest Cancer. 2015;5:61-71doi: 10.2147/GICTT.S72274.
Sendor, A. B., Hacker, K. E., Chen, S., Corona, A. L., Sen, O., Chiang, D. Y., Snavely, A., Rogers, A. B., Montgomery, S. A., Rathmell, W. K., & McRee, A. J. (2015). Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointestinal cancer : targets and therapy, 561-71. https://doi.org/10.2147/GICTT.S72274
Sendor, Adam B, et al. "Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss." Gastrointestinal cancer : targets and therapy vol. 5 (2015): 61-71. doi: https://doi.org/10.2147/GICTT.S72274
Sendor AB, Hacker KE, Chen S, Corona AL, Sen O, Chiang DY, Snavely A, Rogers AB, Montgomery SA, Rathmell WK, McRee AJ. Von Hippel-Lindau status influences phenotype of liver cancers arising from PTEN loss. Gastrointest Cancer. 2015 Feb 01;5:61-71. doi: 10.2147/GICTT.S72274. PMID: 25844041; PMCID: PMC4383253.
Copy Download .nbib Format: NLM
Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011.

Infectious agents and cancer

Yanik EL, Tamburro K, Eron JJ, Damania B, Napravnik S, Dittmer DP.
PMID: 23705808
Infect Agent Cancer. 2013 May 24;8(1):18. doi: 10.1186/1750-9378-8-18.

BACKGROUND: In HIV-infected populations in developed countries, the most recent published cancer incidence trend analyses are only updated through 2008. We assessed changes in the distribution of cancer types and incidence trends among HIV-infected patients in North Carolina up...

Cite
Yanik EL, Tamburro K, Eron JJ, et al. Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infect Agent Cancer. 2013;8(1):18doi: 10.1186/1750-9378-8-18.
Yanik, E. L., Tamburro, K., Eron, J. J., Damania, B., Napravnik, S., & Dittmer, D. P. (2013). Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infectious agents and cancer, 8(1), 18. https://doi.org/10.1186/1750-9378-8-18
Yanik, Elizabeth L, et al. "Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011." Infectious agents and cancer vol. 8,1 (2013): 18. doi: https://doi.org/10.1186/1750-9378-8-18
Yanik EL, Tamburro K, Eron JJ, Damania B, Napravnik S, Dittmer DP. Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011. Infect Agent Cancer. 2013 May 24;8(1):18. doi: 10.1186/1750-9378-8-18. PMID: 23705808; PMCID: PMC3671969.
Copy Download .nbib Format: NLM
Perceptions of Cancer Clinical Research Among African American Men in North Carolina.

Journal of the National Medical Association

Trantham LC, Carpenter WR, DiMartino LD, White B, Green M, Teal R, Corbie-Smith G, Godley PA.
PMID: 26113749
J Natl Med Assoc. 2015 Feb;107(1):33-41. doi: 10.1016/S0027-9684(15)30007-9. Epub 2015 Dec 02.

ACKNOWLEDGEMENTS: The authors are grateful to the men and women who participated in our Focus Groups and shared with us their very personal cancer experience. Their insight is valuable, and will inform and improve cancer care for future generations....

Cite
Trantham LC, Carpenter WR, DiMartino LD, et al. Perceptions of Cancer Clinical Research Among African American Men in North Carolina. J Natl Med Assoc. 2015;107(1):33-41doi: 10.1016/S0027-9684(15)30007-9.
Trantham, L. C., Carpenter, W. R., DiMartino, L. D., White, B., Green, M., Teal, R., Corbie-Smith, G., & Godley, P. A. (2015). Perceptions of Cancer Clinical Research Among African American Men in North Carolina. Journal of the National Medical Association, 107(1), 33-41. https://doi.org/10.1016/S0027-9684(15)30007-9
Trantham, Laurel C, et al. "Perceptions of Cancer Clinical Research Among African American Men in North Carolina." Journal of the National Medical Association vol. 107,1 (2015): 33-41. doi: https://doi.org/10.1016/S0027-9684(15)30007-9
Trantham LC, Carpenter WR, DiMartino LD, White B, Green M, Teal R, Corbie-Smith G, Godley PA. Perceptions of Cancer Clinical Research Among African American Men in North Carolina. J Natl Med Assoc. 2015 Feb;107(1):33-41. doi: 10.1016/S0027-9684(15)30007-9. Epub 2015 Dec 02. PMID: 26113749; PMCID: PMC4477827.
Copy Download .nbib Format: NLM
Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics.

Seminars in colon & rectal surgery

Sanoff HK, McLeod HL.
PMID: 19956343
Semin Colon Rectal Surg. 2008 Dec;19(4):226-230. doi: 10.1053/j.scrs.2008.09.007.

No abstract available.

Cite
Sanoff HK, McLeod HL. Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics. Semin Colon Rectal Surg. 2008;19(4):226-230doi: 10.1053/j.scrs.2008.09.007.
Sanoff, H. K., & McLeod, H. L. (2008). Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics. Seminars in colon & rectal surgery, 19(4), 226-230. https://doi.org/10.1053/j.scrs.2008.09.007
Sanoff, Hanna K, and McLeod, Howard L. "Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics." Seminars in colon & rectal surgery vol. 19,4 (2008): 226-230. doi: https://doi.org/10.1053/j.scrs.2008.09.007
Sanoff HK, McLeod HL. Predictive Factors for Response and Toxicity in Chemotherapy: Pharmacogenomics. Semin Colon Rectal Surg. 2008 Dec;19(4):226-230. doi: 10.1053/j.scrs.2008.09.007. PMID: 19956343; PMCID: PMC2614280.
Copy Download .nbib Format: NLM
Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer.

Gastrointestinal cancer research : GCR

Chakraborty S, Morris MM, Bauer TW, Adams RB, Stelow EB, Petroni G, Sanoff HK.
PMID: 24558510
Gastrointest Cancer Res. 2014 Jan;7(1):15-22.

BACKGROUND: A standard neoadjuvant regimen has not been defined for borderline resectable (BR) pancreatic cancer. This phase II trial was designed to determine the safety of accelerated fraction radiotherapy (AFRT) with capecitabine in patients with BR pancreatic cancer.METHODS: The...

Cite
Chakraborty S, Morris MM, Bauer TW, et al. Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer. Gastrointest Cancer Res. 2014;7(1):15-22
Chakraborty, S., Morris, M. M., Bauer, T. W., Adams, R. B., Stelow, E. B., Petroni, G., & Sanoff, H. K. (2014). Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer. Gastrointestinal cancer research : GCR, 7(1), 15-22.
Chakraborty, Samhita, et al. "Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer." Gastrointestinal cancer research : GCR vol. 7,1 (2014): 15-22.
Chakraborty S, Morris MM, Bauer TW, Adams RB, Stelow EB, Petroni G, Sanoff HK. Accelerated fraction radiotherapy with capecitabine as neoadjuvant therapy for borderline resectable pancreatic cancer. Gastrointest Cancer Res. 2014 Jan;7(1):15-22. PMID: 24558510; PMCID: PMC3924761.
Copy Download .nbib Format: NLM
Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin.

Cell

Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van't Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA, Benz CC, Perou CM, Stuart JM.
PMID: 25109877
Cell. 2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 07.

Recent genomic analyses of pathologically defined tumor types identify "within-a-tissue" disease subtypes. However, the extent to which genomic signatures are shared across tissues is still unclear. We performed an integrative analysis using five genome-wide platforms and one proteomic platform...

Cite
Hoadley KA, Yau C, Wolf DM, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014;158(4):929-944doi: 10.1016/j.cell.2014.06.049.
Hoadley, K. A., Yau, C., Wolf, D. M., Cherniack, A. D., Tamborero, D., Ng, S., Leiserson, M. D. M., Niu, B., McLellan, M. D., Uzunangelov, V., Zhang, J., Kandoth, C., Akbani, R., Shen, H., Omberg, L., Chu, A., Margolin, A. A., Van't Veer, L. J., Lopez-Bigas, N., Laird, P. W., Raphael, B. J., Ding, L., Robertson, A. G., Byers, L. A., Mills, G. B., Weinstein, J. N., Van Waes, C., Chen, Z., Collisson, E. A., Benz, C. C., Perou, C. M., & Stuart, J. M. (2014). Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell, 158(4), 929-944. https://doi.org/10.1016/j.cell.2014.06.049
Hoadley, Katherine A, et al. "Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin." Cell vol. 158,4 (2014): 929-944. doi: https://doi.org/10.1016/j.cell.2014.06.049
Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van't Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA, Benz CC, Perou CM, Stuart JM. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell. 2014 Aug 14;158(4):929-944. doi: 10.1016/j.cell.2014.06.049. Epub 2014 Aug 07. PMID: 25109877; PMCID: PMC4152462.
Copy Download .nbib Format: NLM
Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Moore PJ, Reidel B, Ghosh A, Sesma J, Kesimer M, Tarran R.
PMID: 29890087
FASEB J. 2018 Jun 11;fj201800345R. doi: 10.1096/fj.201800345R. Epub 2018 Jun 11.

Chronic obstructive pulmonary disease (COPD) is a growing cause of morbidity and mortality worldwide. Cigarette smoke (CS) exposure, a major cause of COPD, dysregulates airway epithelial ion transport and diminishes airway surface liquid (ASL) volume. Short palate lung and...

Cite
Moore PJ, Reidel B, Ghosh A, et al. Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration. FASEB J. 2018;fj201800345Rdoi: 10.1096/fj.201800345R.
Moore, P. J., Reidel, B., Ghosh, A., Sesma, J., Kesimer, M., & Tarran, R. (2018). Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201800345R. https://doi.org/10.1096/fj.201800345R
Moore, Patrick J, et al. "Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration." FASEB journal : official publication of the Federation of American Societies for Experimental Biology vol. (2018): fj201800345R. doi: https://doi.org/10.1096/fj.201800345R
Moore PJ, Reidel B, Ghosh A, Sesma J, Kesimer M, Tarran R. Cigarette smoke modifies and inactivates SPLUNC1, leading to airway dehydration. FASEB J. 2018 Jun 11;fj201800345R. doi: 10.1096/fj.201800345R. Epub 2018 Jun 11. PMID: 29890087; PMCID: PMC6219833.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 239 entries